STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Q-Med (STO:QMED) * Group revenues from sales of goods and royalties amounted to 665.0 (686.2) MSEK during the period. * Growth within the Esthetics product area was 17 percent and revenues amounted to 537.1 (460.8) MSEK. * Operating income amounted to 318.2 (212.9) MSEK and the operating margin was 47.9 (34.7) percent.
